| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.042 | 0.5 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.055 | 0.5 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.059 | 0.5 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.037 | 0.5 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.5 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |